This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Taro Masunaga: Innovator in Pharmaceutical Chemistry
Introduction
Taro Masunaga is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Masunaga holds a patent for "Pyrazinyl hydroxyacrylamide compounds having an inhibitory effect on the activity of histone deacetylase." This invention relates to novel N-hydroxyacrylamide compounds and their pharmaceutically acceptable salts. These compounds act as HDAC inhibitors, which are crucial in the treatment and prevention of HDAC-related diseases.
Career Highlights
Taro Masunaga is associated with Astellas Pharma GmbH, where he applies his expertise in drug development. His work focuses on creating innovative solutions that address complex health issues.
Collaborations
Masunaga collaborates with esteemed colleagues such as Fumiyuki Shirai and Hideo Tsutsumi. Their combined efforts contribute to advancements in pharmaceutical research and development.
Conclusion
Taro Masunaga's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions continue to pave the way for new therapeutic options.